Cleared Abbreviated

K101445 - VITAL SIGNS MONITOR-VSM 6000 SERIES

K101445 is the FDA 510(k) clearance for VITAL SIGNS MONITOR-VSM 6000 SERIES by Welch Allyn, Inc.. It is a Class 2 Cardiovascular device (product code MWI) cleared through the Abbreviated 510(k) pathway after a 15-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2010
Decision
15d
Days
Class 2
Risk

K101445 is an FDA 510(k) clearance for the VITAL SIGNS MONITOR-VSM 6000 SERIES. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Welch Allyn, Inc. (Skaneateles Falls, US). The FDA issued a Cleared decision on June 8, 2010 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Welch Allyn, Inc. devices

Submission Details

510(k) Number K101445 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2010
Decision Date June 08, 2010
Days to Decision 15 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 125d · This submission: 15d
Pathway characteristics
Standards-based clearance path. Third-party reviewed.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Intertek Testing Services
DANIEL W LEHTONEN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 123
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K101445.
CONNEX VITAL SIGNS MONITOR 6000 SERIES
K110516 · Welch Allyn, Inc. · Jun 2011
CARESCAPE MODEL V100 VITAL SIGNS MONITOR
K102426 · Ge Medical Systems Information Technologies · Oct 2010
V-TRUST TD-8002 MULTI-PARAMETER SPOT-CHECK MONITOR MODEL TD-8002
K101259 · Taidoc Technology Corporation · Jun 2010
INTELLIBRIDGE SYSTEM
K093177 · Philips Medical Systems · Dec 2009
OMRON MODEL HBP-2070 VITAL SIGNS MONITOR
K082812 · Omron Healthcare, Inc. · Oct 2008
MODIFICATION TO: UNITY NETWORK ID
K071982 · Ge Medical Systems Information Technologies · Sep 2007

Related FDA 510(k) Regulatory Insights